4FRONT-1 - 4D-150-C003 - Clinical Trial
¿Cuál es el Propósito de este estudio?
This study is trying to find out how well a new medicine called 4D-150 works compared to a medicine called Eylea in adults who have a kind of eye disease called wet age-related macular degeneration (wet AMD). The medicine is given as a shot directly into the eye. The study also wants to make sure the new medicine is safe and lasts a long time.
Macular Neovascularization Secondary to Age-Related Macular Degeneration (wet AMD)
¿Quién puede participar en el Estudio?
People in this study must:
- Be 50 years old or older.
- Have never had treatment for their eye condition before.
- Have never had a problem called retinal detachment, which is when part of the eye pulls away from where it should be.
¿Qué Implica?
People in this study will be part of it for about 110 weeks, which is a little more than 2 years. During that time, they will need to visit the study clinic at least 30 times. At each visit, they will have tests and check-ups that are part of their regular care and also for the study.
Detalles del Estudio
